Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Drug Design by Pharmacophore and Virtual Screening Approach
Deborah Giordano, Carmen Biancaniello, Maria Antonia Argenio, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 5, pp. 646-646
Open Access | Times Cited: 184

Showing 1-25 of 184 citing articles:

Anticancer Drug Discovery Based on Natural Products: From Computational Approaches to Clinical Studies
Pritee Chunarkar Patil, Mohammed Kaleem, Richa Mishra, et al.
Biomedicines (2024) Vol. 12, Iss. 1, pp. 201-201
Open Access | Times Cited: 69
The role and potential of computer-aided drug discovery strategies in the discovery of novel antimicrobials
Samson O. Oselusi, Phumuzile Dube, Adeshina I. Odugbemi, et al.
Computers in Biology and Medicine (2024) Vol. 169, pp. 107927-107927
Open Access | Times Cited: 18
A combination of virtual screening, molecular dynamics simulation, MM/PBSA, ADMET, and DFT calculations to identify a potential DPP4 inhibitor
Fatemeh Zare, Elaheh Ataollahi, Pegah Mardaneh, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 16
Application of Mathematical Modeling and Computational Tools in the Modern Drug Design and Development Process
Md. Rifat Hasan, Ahad Amer Alsaiari, Burhan Zain Fakhurji, et al.
Molecules (2022) Vol. 27, Iss. 13, pp. 4169-4169
Open Access | Times Cited: 50
Computer-Aided Drug Design towards New Psychotropic and Neurological Drugs
Georgia Dorahy, Zheng Chen, Thomas Balle
Molecules (2023) Vol. 28, Iss. 3, pp. 1324-1324
Open Access | Times Cited: 29
Multi-target drugs for Alzheimer's disease
Bengisu Turgutalp, Çağhan Kızıl
Trends in Pharmacological Sciences (2024) Vol. 45, Iss. 7, pp. 628-638
Closed Access | Times Cited: 12
Molecular similarity in chemical informatics and predictive toxicity modeling: from quantitative read-across (q-RA) to quantitative read-across structure–activity relationship (q-RASAR) with the application of machine learning
Arkaprava Banerjee, Supratik Kar, Kunal Roy, et al.
Critical Reviews in Toxicology (2024) Vol. 54, Iss. 9, pp. 659-684
Closed Access | Times Cited: 10
A Chronicle Review of In-Silico Approaches for Discovering Novel Antimicrobial Agents to Combat Antimicrobial Resistance
Nagarjuna Prakash Dalbanjan, S. K. Praveen Kumar
Indian Journal of Microbiology (2024) Vol. 64, Iss. 3, pp. 879-893
Closed Access | Times Cited: 8
Computational Chemistry in Structure-Based Solute Carrier Transporter Drug Design: Recent Advances and Future Perspectives
Gao Tu, Tingting Fu, Guoxun Zheng, et al.
Journal of Chemical Information and Modeling (2024) Vol. 64, Iss. 5, pp. 1433-1455
Closed Access | Times Cited: 7
Advances in the discovery of new chemotypes through ultra-large library docking
Felix Potlitz, Andreas Link, Lukas Schulig
Expert Opinion on Drug Discovery (2023) Vol. 18, Iss. 3, pp. 303-313
Closed Access | Times Cited: 16
Deciphering the Lexicon of Protein Targets: A Review on Multifaceted Drug Discovery in the Era of Artificial Intelligence
Suvendu Nandi, Soumyadeep Bhaduri, Debraj Das, et al.
Molecular Pharmaceutics (2024) Vol. 21, Iss. 4, pp. 1563-1590
Closed Access | Times Cited: 6
Prediction of medicinal properties using mathematical models and computation, and selection of plant materials
Sanjoy Singh Ningthoujam, Rajat Nath, Satyajit D. Sarker, et al.
Elsevier eBooks (2024), pp. 91-123
Closed Access | Times Cited: 5
Synthesis, Biological and Molecular Docking Studies of Thiazole‐Thiadiazole derivatives as potential Anti‐Tuberculosis Agents
Samin A. Shaikh, Shivaji R. Labhade, Raju R. Kale, et al.
Chemistry & Biodiversity (2024) Vol. 21, Iss. 6
Closed Access | Times Cited: 5
Exploring the structure-activity relationship (SAR) of Schiff bases as effective compounds in scavenging free radicals
Ianka Jacondino Nunes, Renieidy Fávia Clemente Dias, Alecia F. da Silva, et al.
Journal of Molecular Structure (2024) Vol. 1315, pp. 138729-138729
Closed Access | Times Cited: 5
In silico assessment of biocompatibility and toxicity: molecular docking and dynamics simulation of PMMA-based dental materials for interim prosthetic restorations
Ravinder Saini, Rayan Ibrahim H. Binduhayyim, Vishwanath Gurumurthy, et al.
Journal of Materials Science Materials in Medicine (2024) Vol. 35, Iss. 1
Open Access | Times Cited: 5
Computational evaluation and benchmark study of 342 crystallographic holo-structures of SARS-CoV-2 Mpro enzyme
Hamlet Khachatryan, Mher Matevosyan, Vardan Harutyunyan, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 5
Structure-Based Discovery of MolPort-137: A Novel Autotaxin Inhibitor That Improves Paclitaxel Efficacy
Prateek Rai, Christopher J. Clark, Vandana Kardam, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 2, pp. 597-597
Open Access
Integrating Hydrogen Exchange with Molecular Dynamics for Improved Ligand Binding Predictions
Benjamin T. Walters, Alexander W. Patapoff, James R. Kiefer, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Pharmacophore-guided computational modeling of quinolone-ATPase conjugate inhibitors targeting DNA GyrB subunit of Staphylococcus aureus
Md. Al Amin, Md. Jakir Hossain, Md. Kawsar Habib, et al.
Computers in Biology and Medicine (2025) Vol. 186, pp. 109727-109727
Closed Access
Advances in the Development of Mitochondrial Pyruvate Carrier Inhibitors for Therapeutic Applications
Henry Politte, Lingaiah Maram, Bahaa Elgendy
Biomolecules (2025) Vol. 15, Iss. 2, pp. 223-223
Open Access
Eltrombopag Inhibited Liver Cancer by Enhancing SMYD4 Protein Degradationvia TRIP12 Ubiquitinase
Jiale Li, Qiqiang Zhang, Chunyan Wang, et al.
Advanced Therapeutics (2025)
Closed Access
New strategies to enhance the efficiency and precision of drug discovery
Qi An, Liang Huang, Chuan Wang, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Computational approaches: atom-based 3D-QSAR, molecular docking, ADME-Tox, MD simulation and DFT to find novel multi-targeted anti-tubercular agents
Debadash Panigrahi, Susanta Kumar Sahu
BMC Chemistry (2025) Vol. 19, Iss. 1
Open Access
Computational approaches to aid PROTAC drug discovery
Sohini Chakraborti, Kirsten McAulay
Elsevier eBooks (2025)
Closed Access
Quinazoline-2,4(1H,3H)-dione modulates STAT3 and FOXO3a signaling in HepG2 cells
Suryaa Manoharan, Krishnasanthiya Murugesan, S. Gunasekaran, et al.
Bioorganic Chemistry (2025) Vol. 157, pp. 108304-108304
Closed Access
Page 1 - Next Page

Scroll to top